Bentley Systems Announces Seequent’s Acquisition of Minalytix
14.9.2021 23:01:00 EEST | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that its Seequent business unit has acquired Canadian software company Minalytix, the developer of MX Deposit. The acquisition extends Seequent’s cloud capabilities and solutions for mining, including greenfield exploration, resource development, and mining production. Prior to the transaction, Seequent held a minority shareholding in Minalytix, and its partnership included exclusive global rights to sell MX Deposit.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914006105/en/
Seequent already integrates its Leapfrog, Oasis montaj, Target, and Imago solutions with MX Deposit, streamlining processes and increasing efficiency for geologists, engineers, and other stakeholders. For example, users can easily pull data captured in MX Deposit into Target to generate sections or Leapfrog Geo for 3D modeling and analysis of drill hole data. Teams can collaborate on models with Seequent Central and share with stakeholders using Leapfrog Viewer. (Photo: Business Wire)
MX Deposit simplifies and controls how drill hole and other field data is collected, managed, and shared throughout the lifecycle of a deposit. Mining exploration teams can configure the solution for various activities, including diamond and percussive drilling, grade control, underground face sampling, metallurgical sampling, stockpile sampling, and sampling mill circuits. MX Deposit closes gaps in a project’s data collection, streamlines workflow, reduces errors, and provides an audit trail to improve data confidence and act as a single source of truth for project data. MX Deposit is easy to use and configure and works anywhere online and offline, delivering valuable insights across all mining projects. Real-time collaboration is enabled with live project data.
Mining companies use MX Deposit, in conjunction with other geophysics and geology data management and modeling tools, to find, develop, and manage world-class deposits, and to enable teams to manage risk and make better, more profitable decisions. Data can be easily integrated into MX Deposit in order to provide context that delivers more knowledge and better decision making. Seequent already integrates its Leapfrog, Oasis montaj, Target, and Imago solutions with MX Deposit, streamlining processes and increasing efficiency for geologists, engineers, and other stakeholders. MX Deposit unlocks value from drilling, one of the largest investments for any mining and exploration company, with enduring high-quality data.
MX Deposit is an affordable Software-as-a-Service (SaaS) solution and auto-scales to meet users’ needs, from small to multi-national companies. Users can create a customized data management solution within hours, not days, to collect and control drill hole and other field data and immediately gain insights across all projects. There are no limits on data users can store, with some logging millions of samples and blast holes and tens of thousands of drill holes.
Graham Grant, chief executive officer of Seequent, said, “We’re excited to welcome the Minalytix team to Seequent, following our successful collaboration, to broaden the mining workflow through further cloud capabilities. Drill and sample data are the lifeblood for mining companies when exploring, and MX Deposit naturally aligns with our mining and exploration portfolio, including newly acquired geoscientific imagery platform Imago. We have already done a great job of integrating the software and now we are excited to integrate the team.”
Minalytix Co-founder and CEO David Peres said, “We’re delighted to join Seequent as it allows us to deliver on our founding mission to impact the mining industry positively. We partnered exclusively with Seequent a couple of years ago as they had earned a reputation as a trusted mining innovator with a global reach. As a result, demand for MX Deposit increased in leaps and bounds. With Seequent’s expertise and support, MX Deposit will be able to reach its full potential.”
For more information, please visit https://www.mxdeposit.net/
Caption: Seequent already integrates its Leapfrog, Oasis montaj, Target, and Imago solutions with MX Deposit, streamlining processes and increasing efficiency for geologists, engineers, and other stakeholders. For example, users can easily pull data captured in MX Deposit into Target to generate sections or Leapfrog Geo for 3D modeling and analysis of drill hole data. Teams can collaborate on models with Seequent Central and share with stakeholders using Leapfrog Viewer.
Caption: MX Deposit harnesses the collective power of a team to unlock value from drilling and sampling data. Users can build in important data validation rules into the system and collect quality data that will stand the test of time. A real-time activity feed allows team members to post comments and questions globally or to a specific group of people. In addition, users can tag images and comments to particular drill holes, samples, tables, records or values within a record. As a result, a complete audit trail is captured on every piece of data.
Caption: MX Deposit closes gaps in a project’s data collection from sample collection to lab analysis, ensuring company-wide consistency. Users can import assay results from a laptop in the office and even when off the grid in remote areas can grab samples with native Android and iOS applications that enable work fully offline. Data is automatically synced to the web application once users are back online.
##
About Seequent
Seequent, a Bentley company, is a world leader in the development of powerful geoscience analysis, modeling, and collaborative technologies for understanding geoscience and engineering design solutions. Our solutions enable people to analyze complex data, manage risk, and ultimately make better decisions about earth, environment, and energy challenges.
Seequent software is used on large-scale projects globally, including road and rail tunnel construction, groundwater detection and management, geothermal exploration, subsea infrastructure mapping, resource evaluation, and subterranean storage of spent nuclear fuel.
Seequent’s global footprint includes its Christchurch-based HQ and R&D centers in Christchurch and Canada with a network of offices across Asia/Pacific, Africa, South America, North America, and Europe, servicing organizations with leading subsurface solutions in over 100 countries. For more information, please visit www.seequent.com or follow Seequent on LinkedIn or Twitter.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geosciences software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $800 million in 172 countries.
www.bentley.com
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, Imago, iTwin, Leapfrog, Leapfrog Geo, MicroStation, Minalytix, MX Deposit, Oasis montaj, ProjectWise, Seequent, the Seequent logo, and Target are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210914006105/en/
Contact information
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom